Venus Concept, Inc. (VERO)
0.3105
0.00 (0.00%)
USD |
OTCM |
Apr 07, 16:00
Venus Concept Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 64.00% |
| June 30, 2025 | 60.10% |
| March 31, 2025 | 64.17% |
| December 31, 2024 | 69.07% |
| September 30, 2024 | 66.11% |
| June 30, 2024 | 71.46% |
| March 31, 2024 | 66.63% |
| December 31, 2023 | 66.53% |
| September 30, 2023 | 69.17% |
| June 30, 2023 | 70.83% |
| March 31, 2023 | 66.72% |
| December 31, 2022 | 65.01% |
| September 30, 2022 | 62.09% |
| June 30, 2022 | 69.85% |
| March 31, 2022 | 67.27% |
| December 31, 2021 | 69.98% |
| September 30, 2021 | 70.46% |
| June 30, 2021 | 72.47% |
| March 31, 2021 | 67.42% |
| December 31, 2020 | 64.70% |
| Date | Value |
|---|---|
| September 30, 2020 | 65.30% |
| June 30, 2020 | 70.00% |
| March 31, 2020 | 63.96% |
| December 31, 2019 | 61.99% |
| September 30, 2019 | 71.76% |
| June 30, 2019 | 72.16% |
| March 31, 2019 | 73.49% |
| December 31, 2018 | 76.96% |
| September 30, 2018 | 44.73% |
| June 30, 2018 | 54.08% |
| March 31, 2018 | 36.36% |
| December 31, 2017 | 47.11% |
| September 30, 2017 | 40.77% |
| June 30, 2017 | 39.77% |
| March 31, 2017 | 43.54% |
| December 31, 2016 | 38.90% |
| September 30, 2016 | 34.60% |
| June 30, 2016 | 31.02% |
| March 31, 2016 | 24.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Hypertension Diagnostics, Inc. | -- |
| Avitar, Inc. | -- |
| Abbott Laboratories | 57.05% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.30% |